129 related articles for article (PubMed ID: 33387733)
1. New lipophilic glycomimetic DC-SIGN ligands: Stereoselective synthesis and SPR-based binding inhibition assays.
Di Pietro S; Bordoni V; Iacopini D; Achilli S; Pineschi M; Thépaut M; Fieschi F; Crotti P; Di Bussolo V
Bioorg Chem; 2021 Feb; 107():104566. PubMed ID: 33387733
[TBL] [Abstract][Full Text] [Related]
2. Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection.
Luczkowiak J; Sattin S; Sutkevičiūtė I; Reina JJ; Sánchez-Navarro M; Thépaut M; Martínez-Prats L; Daghetti A; Fieschi F; Delgado R; Bernardi A; Rojo J
Bioconjug Chem; 2011 Jul; 22(7):1354-65. PubMed ID: 21650462
[TBL] [Abstract][Full Text] [Related]
3. Facile access to pseudo-thio-1,2-dimannoside, a new glycomimetic DC-SIGN antagonist.
Tamburrini A; Achilli S; Vasile F; Sattin S; Vivès C; Colombo C; Fieschi F; Bernardi A
Bioorg Med Chem; 2017 Oct; 25(19):5142-5147. PubMed ID: 28389114
[TBL] [Abstract][Full Text] [Related]
4. Noncarbohydrate glycomimetics and glycoprotein surrogates as DC-SIGN antagonists and agonists.
Prost LR; Grim JC; Tonelli M; Kiessling LL
ACS Chem Biol; 2012 Sep; 7(9):1603-8. PubMed ID: 22747463
[TBL] [Abstract][Full Text] [Related]
5. Polyvalent C-glycomimetics based on l-fucose or d-mannose as potent DC-SIGN antagonists.
Bertolotti B; Sutkeviciute I; Ambrosini M; Ribeiro-Viana R; Rojo J; Fieschi F; Dvořáková H; Kašáková M; Parkan K; Hlaváčková M; Nováková K; Moravcová J
Org Biomol Chem; 2017 May; 15(18):3995-4004. PubMed ID: 28443908
[TBL] [Abstract][Full Text] [Related]
6. Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.
Varga N; Sutkeviciute I; Guzzi C; McGeagh J; Petit-Haertlein I; Gugliotta S; Weiser J; Angulo J; Fieschi F; Bernardi A
Chemistry; 2013 Apr; 19(15):4786-97. PubMed ID: 23417900
[TBL] [Abstract][Full Text] [Related]
7. Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition.
Porkolab V; Chabrol E; Varga N; Ordanini S; Sutkevičiu Tė I; Thépaut M; García-Jiménez MJ; Girard E; Nieto PM; Bernardi A; Fieschi F
ACS Chem Biol; 2018 Mar; 13(3):600-608. PubMed ID: 29272097
[TBL] [Abstract][Full Text] [Related]
8. Unique DC-SIGN clustering activity of a small glycomimetic: A lesson for ligand design.
Sutkeviciute I; Thépaut M; Sattin S; Berzi A; McGeagh J; Grudinin S; Weiser J; Le Roy A; Reina JJ; Rojo J; Clerici M; Bernardi A; Ebel C; Fieschi F
ACS Chem Biol; 2014 Jun; 9(6):1377-85. PubMed ID: 24749535
[TBL] [Abstract][Full Text] [Related]
9. Nonhydrolyzable C-disaccharides, a new class of DC-SIGN ligands.
Bertolotti B; Oroszová B; Sutkeviciute I; Kniežo L; Fieschi F; Parkan K; Lovyová Z; Kašáková M; Moravcová J
Carbohydr Res; 2016 Nov; 435():7-18. PubMed ID: 27676269
[TBL] [Abstract][Full Text] [Related]
10. Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin.
Andreini M; Doknic D; Sutkeviciute I; Reina JJ; Duan J; Chabrol E; Thepaut M; Moroni E; Doro F; Belvisi L; Weiser J; Rojo J; Fieschi F; Bernardi A
Org Biomol Chem; 2011 Aug; 9(16):5778-86. PubMed ID: 21735039
[TBL] [Abstract][Full Text] [Related]
11. Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
Tomašić T; Hajšek D; Švajger U; Luzar J; Obermajer N; Petit-Haertlein I; Fieschi F; Anderluh M
Eur J Med Chem; 2014 Mar; 75():308-26. PubMed ID: 24556146
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists.
Obermajer N; Sattin S; Colombo C; Bruno M; Svajger U; Anderluh M; Bernardi A
Mol Divers; 2011 May; 15(2):347-60. PubMed ID: 21076980
[TBL] [Abstract][Full Text] [Related]
13. A general glycomimetic strategy yields non-carbohydrate inhibitors of DC-SIGN.
Garber KC; Wangkanont K; Carlson EE; Kiessling LL
Chem Commun (Camb); 2010 Sep; 46(36):6747-9. PubMed ID: 20717628
[TBL] [Abstract][Full Text] [Related]
14. Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2.
Cramer J; Lakkaichi A; Aliu B; Jakob RP; Klein S; Cattaneo I; Jiang X; Rabbani S; Schwardt O; Zimmer G; Ciancaglini M; Abreu Mota T; Maier T; Ernst B
J Am Chem Soc; 2021 Oct; 143(42):17465-17478. PubMed ID: 34652144
[TBL] [Abstract][Full Text] [Related]
15. High-affinity glycopolymer binding to human DC-SIGN and disruption of DC-SIGN interactions with HIV envelope glycoprotein.
Becer CR; Gibson MI; Geng J; Ilyas R; Wallis R; Mitchell DA; Haddleton DM
J Am Chem Soc; 2010 Nov; 132(43):15130-2. PubMed ID: 20932025
[TBL] [Abstract][Full Text] [Related]
16. Short Communication: Inhibition of DC-SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Receptor Antagonists and Env-Targeting Virus Inactivators.
Pustylnikov S; Dave RS; Khan ZK; Porkolab V; Rashad AA; Hutchinson M; Fieschi F; Chaiken I; Jain P
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):93-100. PubMed ID: 26383762
[TBL] [Abstract][Full Text] [Related]
17. DC-SIGN antagonists, a potential new class of anti-infectives.
Anderluh M; Jug G; Svajger U; Obermajer N
Curr Med Chem; 2012; 19(7):992-1007. PubMed ID: 22257062
[TBL] [Abstract][Full Text] [Related]
18. STD NMR and molecular modelling insights into interaction of novel mannose-based ligands with DC-SIGN.
Kotar A; Tomašič T; Lenarčič Živković M; Jug G; Plavec J; Anderluh M
Org Biomol Chem; 2016 Jan; 14(3):862-75. PubMed ID: 26580315
[TBL] [Abstract][Full Text] [Related]
19. Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.
Thépaut M; Guzzi C; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Varga N; Chabrol E; Rojo J; Bernardi A; Angulo J; Nieto PM; Fieschi F
J Am Chem Soc; 2013 Feb; 135(7):2518-29. PubMed ID: 23360500
[TBL] [Abstract][Full Text] [Related]
20. Saturation transfer difference (STD) NMR spectroscopy characterization of dual binding mode of a mannose disaccharide to DC-SIGN.
Angulo J; Díaz I; Reina JJ; Tabarani G; Fieschi F; Rojo J; Nieto PM
Chembiochem; 2008 Sep; 9(14):2225-7. PubMed ID: 18720494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
